Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemours (CC) EBT Margin (2016 - 2025)

Chemours has reported EBT Margin over the past 12 years, most recently at 5.04% for Q4 2025.

  • Quarterly results put EBT Margin at 5.04% for Q4 2025, down 511.0% from a year ago — trailing twelve months through Dec 2025 was 4.99% (down 686.0% YoY), and the annual figure for FY2025 was 4.77%, down 1037.0%.
  • EBT Margin for Q4 2025 was 5.04% at Chemours, down from 2.54% in the prior quarter.
  • Over the last five years, EBT Margin for CC hit a ceiling of 16.83% in Q3 2022 and a floor of 26.08% in Q2 2023.
  • Median EBT Margin over the past 5 years was 1.7% (2023), compared with a mean of 0.58%.
  • Biggest five-year swings in EBT Margin: plummeted -3815bps in 2023 and later surged 3052bps in 2024.
  • Chemours' EBT Margin stood at 20.95% in 2021, then surged by 75bps to 5.16% in 2022, then fell by -1bps to 5.19% in 2023, then skyrocketed by 101bps to 0.07% in 2024, then plummeted by -6951bps to 5.04% in 2025.
  • The last three reported values for EBT Margin were 5.04% (Q4 2025), 2.54% (Q3 2025), and 15.36% (Q2 2025) per Business Quant data.